California State Teachers Retirement System (CalSTRS)’s Bolt Biotherapeutics BOLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,052
Closed -$58K 3155
2022
Q1
$58K Sell
1,052
-153
-13% -$10.3K ﹤0.01% 2992
2021
Q4
$118K Buy
1,205
+43
+4% +$8.16K ﹤0.01% 2948
2021
Q3
$294K Buy
1,162
+364
+46% +$103K ﹤0.01% 2604
2021
Q2
$247K Sell
798
-159
-17% -$64.5K ﹤0.01% 2959
2021
Q1
$630K Buy
+957
New +$623K ﹤0.01% 2417

Other funds holding BOLT

California State Teachers Retirement System (CalSTRS)'s BOLT Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Bolt Biotherapeutics (BOLT) in Q2 2022, closing a stake of 1,052 shares — an estimated $58K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in BOLT in Q1 2021 and held it in 5 quarters. The position peaked at $630K in Q1 2021. 61 funds tracked by Wall St. Rank hold BOLT as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Bolt Biotherapeutics position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,052 Bolt Biotherapeutics shares in Q2 2022, an estimated $58K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 5 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Bolt Biotherapeutics position peaked at $630K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.